Citations for
1AFDN, ARHGAP29
Afadin Facilitates Vascular Endothelial Growth Factor-Induced Network Formation and Migration of Vascular Endothelial Cells by Inactivating Rho-Associated Kinase Through ArhGAP29.
Tagashira T, Fukuda T, Miyata M, Nakamura K, Fujita H, Takai Y, Hirata KI, Rikitake Y.
Arterioscler Thromb Vasc Biol 38(5):1159-1169. doi: 10.1161/ATVBAHA.118.310991. Epub 2018 Mar 29. 2018
2ARHGAP29, RADIL, RASIP1
Multiple Rap1 effectors control Epac1-mediated tightening of endothelial junctions.
Pannekoek WJ, Vliem MJ, Bos JL.
Small GTPases mall GTPases. 2018 Feb 17:1-8. doi: 10.1080/21541248.2018.1431512. [Epub ahead of print] 2018
3ARHGAP29
ARHGAP29 Mutation Is Associated with Abnormal Oral Epithelial Adhesions.
Paul BJ, Palmer K, Sharp JC, Pratt CH, Murray SA, Dunnwald M.
J Dent Res 96(11):1298-1305. doi: 10.1177/0022034517726079. Epub 2017 Aug 17. 2017
4ARHGAP29
YAP Regulates Actin Dynamics through ARHGAP29 and Promotes Metastasis.
Qiao Y, Chen J, Lim YB, Finch-Edmondson ML, Seshachalam VP, Qin L, Jiang T, Low BC, Singh H, Lim CT, Sudol M.
Cell Rep 19(8):1495-1502. doi: 10.1016/j.celrep.2017.04.075. 2017
5ARHGAP29
Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting.
Liu H, Leslie EJ, Carlson JC, Beaty TH, Marazita ML, Lidral AC, Cornell RA.
Nat Commun 8:14759. doi: 10.1038/ncomms14759. 2017
6ARHGAP29
Exome sequencing provides additional evidence for the involvement of ARHGAP29 in Mendelian orofacial clefting and extends the phenotypic spectrum to isolated cleft palate.
Liu H, Busch T, Eliason S, Anand D, Bullard S, Gowans LJJ, Nidey N, Petrin A, Augustine-Akpan EA, Saadi I, Dunnwald M, Lachke SA, Zhu Y, Adeyemo A, Amendt B, Roscioli T, Cornell R, Murray J, Butali A.
Birth Defects Res 109(1):27-37. doi: 10.1002/bdra.23596. 2017
7ARHGAP29
Impact of rare variants in ARHGAP29 to the etiology of oral clefts: role of loss-of-function vs missense variants.
Savastano CP, Brito LA, Faria ÁC, Setó-Salvia N, Peskett E, Musso CM, Alvizi L, Ezquina SA, James C, GOSgene, Beales P, Lees M, Moore GE, Stanier P, Passos-Bueno MR.
Clin Genet 91(5):683-689. doi: 10.1111/cge.12823. Epub 2016 Jul 26. 2017
8ARHGAP29, RASIP1
Rasip1-Mediated Rho GTPase Signaling Regulates Blood Vessel Tubulogenesis via Nonmuscle Myosin II.
Barry DM, Koo Y, Norden PR, Wylie LA, Xu K, Wichaidit C, Azizoglu DB, Zheng Y, Cobb MH, Davis GE, Cleaver O.
Circ Res 119(7):810-26. doi: 10.1161/CIRCRESAHA.116.309094. Epub 2016 Aug 2. 2016
9ARHGAP29, RADIL, RAP1A, RASIP1
Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.
Post A, Pannekoek WJ, Ponsioen B, Vliem MJ, Bos JL.
Mol Cell Biol 35(14):2495-502. doi: 10.1128/MCB.01453-14. Epub 2015 May 11. 2015
10ARHGAP29
Further evidence suggesting a role for variation in ARHGAP29 variants in nonsyndromic cleft lip/palate.
Letra A, Maili L, Mulliken JB, Buchanan E, Blanton SH, Hecht JT.
Birth Defects Res A Clin Mol Teratol 100(9):679-85. doi: 10.1002/bdra.23286. Epub 2014 Aug 27. 2014
11ARHGAP29, RADIL, RAP1A, RASIP1
Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29.
Post A, Pannekoek WJ, Ross SH, Verlaan I, Brouwer PM, Bos JL.
Proc Natl Acad Sci U S A 110(28):11427-32. doi: 10.1073/pnas.1306595110. Epub 2013 Jun 24. 2013
12ARHGAP29
Expression and mutation analyses implicate ARHGAP29 as the etiologic gene for the cleft lip with or without cleft palate locus identified by genome-wide association on chromosome 1p22.
Leslie EJ, Mansilla MA, Biggs LC, Schuette K, Bullard S, Cooper M, Dunnwald M, Lidral AC, Marazita ML, Beaty TH, Murray JC.
Birth Defects Res A Clin Mol Teratol 94(11):934-42. doi: 10.1002/bdra.23076. Epub 2012 Sep 24. 2012
13ARHGAP29
Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
Ripperger T, von Neuhoff N, Kamphues K, Emura M, Lehmann U, Tauscher M, Schraders M, Groenen P, Skawran B, Rudolph C, Callet-Bauchu E, van Krieken JH, Schlegelberger B, Steinemann D.
Haematologica 92(4):460-8. 2007
14ARHGAP29
PARG1, a protein-tyrosine phosphatase-associated RhoGAP, as a putative Rap2 effector.
Myagmar BE, Umikawa M, Asato T, Taira K, Oshiro M, Hino A, Takei K, Uezato H, Kariya K.
Biochem Biophys Res Commun 329(3):1046-52. 2005
15ARHGAP29
A novel GTPase-activating protein for Rho interacts with a PDZ domain of the protein-tyrosine phosphatase PTPL1.
Saras J, Franzen P, Aspenstrom P, Hellman U, Gonez LJ, Heldin CH.
J Biol Chem 272(39):24333-8. 1997